| Sebastian Cerna, MD | |
|
3315 S Alameda St, Corpus Christi, TX 78411-1883 | |
| (361) 857-1400 | |
| Not Available |
| Full Name | Sebastian Cerna |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 3315 S Alameda St, Corpus Christi, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053309476 | NPI | - | NPPES |
| 139787920 | Medicaid | TX | |
| 8P5501 | Other | TX | BCBSTX PROVIDER NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | J0751 (Texas) | Primary |
| Entity Name | Pinnacle Emergency Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982664801 PECOS PAC ID: 4880671882 Enrollment ID: O20050120000060 |
News Archive
The University of California, Berkeley announced today that it has received a five-year grant expected to total $47 million from the U.S. National Institute on Aging (NIA) to incorporate advanced brain imaging into the Alzheimer's Association's groundbreaking clinical trial, the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER), to determine whether lifestyle changes can protect memory in people at risk of developing dementia.
Scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) have identified a previously unknown gene variant that doubles an individual's risk for obsessive-compulsive disorder (OCD).
Punyamurtula S. Kishore MD, MPH, FASAM, of Preventive Medicine Associates, Inc. (PMAI), the largest outpatient substance dependence provider in Massachusetts, announced today his 37 clinical locations will be offering new addiction treatment options through the use of VIVITROL (naltrexone for extended-release injectable suspension), which was approved on Tuesday, October 12, 2010 by the U.S. Food and Drug Administration (FDA) for the prevention of relapse to opioid dependence.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
Adolescents and young adults who smoke marijuana frequently may attempt to manage negative moods by using the drug, according to a study in September's Journal of Studies on Alcohol and Drugs.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sebastian Cerna, MD Po Box 203331, Houston, TX 77216-3331 Ph: (281) 784-1111 | Sebastian Cerna, MD 3315 S Alameda St, Corpus Christi, TX 78411-1883 Ph: (361) 857-1400 |
News Archive
The University of California, Berkeley announced today that it has received a five-year grant expected to total $47 million from the U.S. National Institute on Aging (NIA) to incorporate advanced brain imaging into the Alzheimer's Association's groundbreaking clinical trial, the U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER), to determine whether lifestyle changes can protect memory in people at risk of developing dementia.
Scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA) have identified a previously unknown gene variant that doubles an individual's risk for obsessive-compulsive disorder (OCD).
Punyamurtula S. Kishore MD, MPH, FASAM, of Preventive Medicine Associates, Inc. (PMAI), the largest outpatient substance dependence provider in Massachusetts, announced today his 37 clinical locations will be offering new addiction treatment options through the use of VIVITROL (naltrexone for extended-release injectable suspension), which was approved on Tuesday, October 12, 2010 by the U.S. Food and Drug Administration (FDA) for the prevention of relapse to opioid dependence.
Orexigen(R) Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, today announced that on December 23, 2009 the Compensation Committee of the Company's Board of Directors approved the grant of inducement stock options to purchase a total of 64,000 shares of common stock to two new employees.
Adolescents and young adults who smoke marijuana frequently may attempt to manage negative moods by using the drug, according to a study in September's Journal of Studies on Alcohol and Drugs.
› Verified 2 days ago
John Herrick, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2606 Hospital Blvd, Corpus Christi, TX 78405 Phone: 361-902-4000 | |
Ben A Leeson, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2606 Hospital Blvd, Emergency Department-memorial, Corpus Christi, TX 78405 Phone: 361-902-4151 | |
Dr. Kimberly Anne Barnes Leeson, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 2606 Hospital Blvd, Corpus Christi, TX 78405 Phone: 361-902-4151 | |
Dr. Phillip Jackson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 4609 Schwerin Lake Dr, Corpus Christi, TX 78413 Phone: 361-808-9383 Fax: 361-808-9383 | |
Marita Rafael, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 3533 S Alameda St, Corpus Christi, TX 78411 Phone: 361-694-5100 | |
Louis Needleman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 5310 Javelina, Corpus Christi, TX 78413 Phone: 361-985-0470 | |
Larry D Johnson, M.D. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3614 Ocean Dr., Corpus Christi, TX 78411 Phone: 361-549-1758 Fax: 281-784-1555 |